Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: penicillins / iodine / platinum complexes / aspirin / shellfish derived attending: chief complaint: gi bleed major surgical or invasive procedure: esophagogastroduodenoscopy history of present illness: ms. is a 43yo female with a history of recurrent stage iiic adenocarcinoma of the ovary who presented today with a gi bleed. she arrived to 9 today for c1d1 of oral topotecan. she was recently transitioned off gemcitabine when a ct scan demonstrated and interval increased size of left pelvic mass, which invaded the pelvic sidewall and likely the small bowel. she was feeling well today, except for a report of fatigue, most specifically when walking. she had her blood counts checked and her hematocrit returned at 21.1 from 28.2 on . she was treated with topotecan. she noted darker stool over the last 24-36 hours, which she attributed to spinach. she went to work after the chemotherapy and had another bowel movement that was described as "sticky." it was a small formed stool, dark/black in color with red/maroon streaks. she discussed this development with her oncologist and was referred to the ed. in the ed, vitals were 125/73 95 18 99% 2l. she was given 1 liter normal saline and 10 units of regular insulin and admitted to the omed team. on the floor, she did well. she was seen by the gi and surgery consult teams. she was transfused 1 unit of blood. the surgical team felt the patient should be monitored in the icu overnight and she was transferred. this evening, she has no specific complaints. she has noted the onset of some chemotherapy side effects, which is typical for her. she denies headache, orthostasis, vision changes, mouth sores, chest pain, palpitations, shortness of breath, abdominal pain, nausea, vomiting, further ostomy output, rectal bleeding, joint pain or rash. past medical history: is 43 yo woman with advanced ovarian ca. she is s/p debulking surgery and hysterectomy and bilateral salpingo-oopherectomy. she received iv and intraperitoneal chemotherapy as part of her adjuvant chemotherapy ending in 7. she was enrolled in study getting oral azd2171 until . she resumed tx with single as of ; but had reaction with dose 6/08. started doxil . had evidence of disease progression so tx changed to alimta on till . tx changed to weekly taxol with avastin on . due to neuropathy from taxol; tx changed to weekly taxotere on . she had sigmoid colon perforation and had colon ressection and colonostomy on . she has been slow to heal and resumed chemo with gemzar on . tx changed to topotecan on . past medical history: diabetes hypothyroidism htn (improved- no meds since ) clear cell ovarian cancer s/p tah-bso, appendectomy, omentectomy s/p sigmoid resection social history: lives by herself in . no tobacco, alcohol, or illicit drugs. family history: many women on mother's side with cancers including lung, colon, gastric, ovarian. physical exam: vs: 98.5 106/54 89 18 98% ra gen: comfortable appearing female, sitting up in bed, in nad heent: nc/at, eomi, pale conjunctiva, mmm, clear oropharynx, no lad cv: rrr, normal s1/s2, no m/r/g pulm: ctab, no wheezing, rubs or rales abd: normoactive bowel sounds, nontender, nondistended, ostomy clear --guaiac positive, dark black stool in ostomy (guaiac reported in omed admit exam) limbs: strength 5/5 in all extremities skin: no skin lesions or rashes noted neuro: cn ii-xii grossly intact pertinent results: admission labs: 08:00am wbc-12.9* rbc-2.85*# hgb-6.5*# hct-21.1*# mcv-74* mch-23.0* mchc-31.0 rdw-21.2* 08:00am plt count-584* 12:30pm glucose-369* urea n-12 creat-0.8 sodium-133 potassium-4.7 chloride-96 total co2-23 anion gap-19 05:40pm fibrinoge-700* 12:30pm pt-10.8 ptt-20.6* inr(pt)-0.9 05:40pm haptoglob-476* 05:40pm alt(sgpt)-9 ast(sgot)-13 ld(ldh)-188 alk phos-109 tot bili-0.3 05:40pm calcium-9.5 phosphate-3.3 magnesium-2.3 hct trends: 08:00am hct-21.1*# 12:30pm hct-21.7* 05:40pm hct-20.3* 01:01am hct-22.7* 06:09am hct-28.7*# 12:32pm hct-24.8* 12:32pm hct-26.7* 08:07pm hct-32.1* 03:59am hct-30.1* 09:45am hct-29.6* 04:40pm hct-28.5* 01:55am hct-29.6* 05:00pm hct-31.2* 06:25am hct-27.1* 01:50pm hct-28.3* 09:35pm hct-27.8* 07:10am hct-28.3* 04:35pm hct-27.3* discharge labs : wbc-8.3 rbc-3.54* hgb-9.1* hct-28.3* mcv-80* mch-25.7* mchc-32.1 rdw-18.4* plt ct-381 glucose-74 urean-13 creat-0.8 na-139 k-4.7 cl-100 hco3-30 angap-14 calcium-9.9 phos-3.7 mg-2.1 microbiology: mrsa screen positive imaging: ekg : sinus tachycardia. late r wave progression. since the previous tracing of t wave abnormalities are less prominent. clinical correlation is suggested. egd : there was a 5 mm inlet patch in the proximal esophagus. in addition, the was a very small (3-4 mm) mucosal erosion in the proximal esophagus that was likely due to the passage of the endoscope. there was no blood in the esophagus or duodenum. otherwise normal egd to fourth part of the duodenum colonoscopy : pus lining the crypt lines on one large fold but no obvious inflammation in the cecum (biopsy) cecum pathology : cecum, biopsy: colonic mucosa, no diagnostic abnormalities recognized. brief hospital course: 43yo female with a history of recurrent stage iiic adenocarcinoma of the ovary who presents with a gi bleed. #. gi bleed: her hematocrit on admission was 20.1 which was decreased from her recent baseline of about 28. she remained hemodynamically stable but was transferred to the icu for monitoring. she was given 4 units of prbcs and had an appropriate hematocrit increase post-transfusion. there was concern that her pelvic mass had invaded her bowel mucosa and vasculature causing a gi bleed. gi was consulted who did an egd and colonoscopy both not revealing for a source of bleeding. patient then had a capsule endoscopy and was discharged home with close follow-up with oncology. she was counseled on warning signs of further bleeding and fatigue. #. dm: she was continued on lantus and ssi. #. recurrent ovarian cancer: she was given her dose of topotecan prior to admission. there was concern for continued growth of her pelvic mass despite recent chemotherapy. she is to follow-up with her primary oncology team a few days after discharge. #. hypothyroidism: continued on home levothyroxine. #. code status: she was full code during this admission. medications on admission: tricor 145mg daily lantus 80u daily humalog sliding scale levothyroxine 100 mcg daily lorazepam 0.25-0.5mg qhs prn insomnia prochlorperazine maleate 10mg po q8 prn nausea crestor 40mg daily tylenol prn discharge medications: 1. levothyroxine 100 mcg tablet sig: one (1) tablet po daily (daily). 2. tricor 145 mg tablet sig: one (1) tablet po once a day. 3. lantus 100 unit/ml solution sig: eighty (80) units subcutaneous once a day. 4. humalog 100 unit/ml solution sig: one (1) subcutaneous four times a day: per sliding scale. 5. lorazepam 0.5 mg tablet sig: 1-2 tablets po at bedtime as needed for insomnia. 6. prochlorperazine maleate 10 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed for nausea. 7. crestor 40 mg tablet sig: one (1) tablet po once a day. 8. acetaminophen 325 mg tablet sig: two (2) tablet po q6h (every 6 hours) as needed for pain, fever. discharge disposition: home discharge diagnosis: primary: melena secondary: ovarian adenocarincoma discharge condition: mental status:clear and coherent level of consciousness:alert and interactive activity status:ambulatory - independent discharge instructions: you were admitted to the hospital for dark stools and a low blood count. you had endoscopies of your upper and lower gi tracts that did not find a source of your bleeding. you had a capsule endoscopy for which we do not yet know the results. no new medications started. followup instructions: you will need to follow up with dr. and dr. this coming friday . you will be contact with the exact time. provider: , md phone: date/time: 10:30 procedure: other endoscopy of small intestine closed [endoscopic] biopsy of large intestine diagnoses: pure hypercholesterolemia unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism long-term (current) use of insulin blood in stool precipitous drop in hematocrit personal history of antineoplastic chemotherapy colostomy status secondary malignant neoplasm of retroperitoneum and peritoneum personal history of malignant neoplasm of ovary 

Answer: The patient is high likely exposed to